Additional file 3 of Application of a framework to guide genetic testing communication across clinical indications
Miranda L. G. Hallquist, Adam H. Buchanan(Geisinger Health System), Melissa Stosic(Columbia University), W. Andrew Faucett(Geisinger Medical Center), Wendy R. Uhlmann(University of Michigan), Maureen E. Smith(Northwestern University), Hannah Wand(Stanford University), Juliann M. Savatt(Geisinger Medical Center), Eric P. Tricou(Stanford University), Julianne O’Daniel(University of North Carolina at Chapel Hill), Howard P. Levy(Johns Hopkins University), Karen E. Wain(Geisinger Medical Center), Laura Hercher(National Society of Genetic Counselors), Kelly E. Ormond(Stanford University), Curtis R. Coughlin(University of Colorado Denver), Holly L. Peay(RTI International)
Cited by 0
Related Papers
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future
|Genetics in Medicine|2013|741
A framework for the classification of joint hypermobility and related conditions
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|597
Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural history
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|482